Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma. [electronic resource] by
- Pantani, L
- Brioli, A
- Tacchetti, P
- Zannetti, B A
- Mancuso, K
- Rocchi, S
- Martello, M
- Rizzello, I
- Terragna, C
- Zamagni, E
- Cavo, M
Producer: 20161213
In:
Expert review of hematology vol. 9
Availability: No items available.
|
|
|
4.
|
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease. [electronic resource] by
- Brioli, A
- Zamagni, E
- Pasquali, S
- Tosi, P
- Tacchetti, P
- Perrone, G
- Pantani, L
- Petrucci, A
- Zannetti, B A
- Baccarani, M
- Cavo, M
Producer: 20130408
In:
Bone marrow transplantation vol. 47
Availability: No items available.
|
|
|
5.
|
Neuropathy in multiple myeloma treated with thalidomide: a prospective study. [electronic resource] by
- Plasmati, R
- Pastorelli, F
- Cavo, M
- Petracci, E
- Zamagni, E
- Tosi, P
- Cangini, D
- Tacchetti, P
- Salvi, F
- Bartolomei, I
- Michelucci, R
- Tassinari, C A
Producer: 20070830
In:
Neurology vol. 69
Availability: No items available.
|
|
|
6.
|
Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma. [electronic resource] by
- Cavo, M
- Pantani, L
- Pezzi, A
- Petrucci, M T
- Patriarca, F
- Di Raimondo, F
- Marzocchi, G
- Galli, M
- Montefusco, V
- Zamagni, E
- Gamberi, B
- Tacchetti, P
- Brioli, A
- Palumbo, A
- Sonneveld, P
Producer: 20160413
In:
Leukemia vol. 29
Availability: No items available.
|
|
|
7.
|
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis. [electronic resource] by
- Martello, M
- Remondini, D
- Borsi, E
- Santacroce, B
- Procacci, M
- Pezzi, A
- Dico, F A
- Martinelli, G
- Zamagni, E
- Tacchetti, P
- Pantani, L
- Testoni, N
- Marzocchi, G
- Rocchi, S
- Zannetti, B A
- Mancuso, K
- Cavo, M
- Terragna, C
Producer: 20170829
In:
Leukemia vol. 30
Availability: No items available.
|
|
|
8.
|
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation. [electronic resource] by
- Brioli, A
- Perrone, G
- Patriarca, F
- Pezzi, A
- Nobile, F
- Ballerini, F
- Motta, M R
- Ronconi, S
- Tacchetti, P
- Catalano, L
- Zannetti, B A
- Rizzi, S
- Volpe, S
- Zamagni, E
- Liberati, A M
- Mancuso, K
- Boccadoro, M
- Davies, F E
- Morgan, G J
- Palumbo, A
- Cavo, M
Producer: 20160125
In:
Bone marrow transplantation vol. 50
Availability: No items available.
|
|
|
9.
|
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease. [electronic resource] by
- Zamagni, E
- Nanni, C
- Gay, F
- Pezzi, A
- Patriarca, F
- Bellò, M
- Rambaldi, I
- Tacchetti, P
- Hillengass, J
- Gamberi, B
- Pantani, L
- Magarotto, V
- Versari, A
- Offidani, M
- Zannetti, B
- Carobolante, F
- Balma, M
- Musto, P
- Rensi, M
- Mancuso, K
- Dimitrakopoulou-Strauss, A
- Chauviè, S
- Rocchi, S
- Fard, N
- Marzocchi, G
- Storto, G
- Ghedini, P
- Palumbo, A
- Fanti, S
- Cavo, M
Producer: 20160722
In:
Leukemia vol. 30
Availability: No items available.
|